EX-99.2 3 dex992.htm PRESS RELEASE Press Release

Exhibit 99.2

LOGO

Calix Reports Historical Quarterly Financial Information

PETALUMA, CA — July 22, 2010 — Calix, Inc. (NYSE: CALX) today publicly released historical quarterly financial information for the quarters ended March 31, 2008 through June 26, 2010.

About Calix

Calix, Inc. (NYSE: CALX) is a leading provider in North America of broadband communications access systems and software for copper- and fiber- based network architectures that enable communications service providers to connect to their residential and business subscribers. Calix enables communications service providers to provide a wide range of revenue-generating services, from basic voice and data to advanced broadband services, over legacy and next-generation access networks. The Calix Unified Access Portfolio helps these companies to transform their legacy and mixed protocol access networks to fiber and Ethernet. Calix has shipped over six million ports of its Unified Access Infrastructure portfolio to more than 500 North American and international customers, whose networks serve over 40 million subscriber lines in total. For more information, visit the Calix website at www.calix.com.

Use of Non-GAAP financial information

The Company uses certain non-GAAP financial measures in the attachments to this press release to supplement its consolidated financial statements, which are presented in accordance with GAAP. These non-GAAP measures are provided to enhance the reader’s understanding of the Company’s operating performance as they exclude certain non-cash charges which the Company believes are not indicative of its core operating results. Management believes that the non-GAAP measures used in the attachments to this press release provide investors with important perspectives into the Company’s ongoing business performance and management uses these non-GAAP measures to evaluate financial results and to establish operational goals. The presentation of these non-GAAP measures is not meant to be a substitute for results presented in accordance with GAAP, but rather should be evaluated in conjunction with these results. A reconciliation of the non-GAAP results to the most directly comparable GAAP results is provided in the attachments to this press release. The non-GAAP financial measures used by the company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.

The Company makes adjustments for the following items in analyzing its operating results as it does not consider these items as part of the Company’s ongoing operating activities or meaningful in evaluating the Company’s financial performance:

Stock-based compensation

A non-cash expense incurred in accordance with SFAS 123R using the modified prospective transition method.

Amortization of acquisition related intangible assets

A non-cash expense resulting from intangible assets acquired in the acquisition of Optical Solutions, Inc. (OSI) in February 2006. The Company is required to amortize these assets over their expected useful lives.


Press Release    Page 2

 

Change in fair value of preferred stock warrants

A non-cash expense or benefit resulting from the revaluation of the Company’s preferred stock warrant liability. Upon completion of the Company’s initial public offering, the preferred warrant liability was reclassified as a component of stockholders’ equity, and the Company is no longer required to revalue the warrants.

Preferred stock dividends

Preferred stock dividends represent Series I preferred stock dividends paid to the Company’s Series I stockholders prior to the conversion of preferred stock into common stock in connection with the Company’s initial public offering.

Investor Relations Contact:

Carolyn Bass

415-445-3232

Carolyn.Bass@Calix.com

Press Contact:

Catherine Koo

415-992-4400

calix@lewispr.com


Press Release    Page 3

 

Calix, Inc.

            

Historical Financials

            

Non-GAAP Income Statements 2010

            

($ in thousands)

            
      GAAP     Non-GAAP     GAAP     Non-GAAP     GAAP     Non-GAAP  
     Qtr  Ending
3/27/2010
    Qtr Ending
3/27/2010
    Qtr  Ending
6/26/2010
    Qtr Ending
6/26/2010
    Ytd  Ending
6/26/2010
    Ytd  Ending
6/26/2010
 
            

Revenue

   $ 48,203      $ 48,203      $ 71,653      $ 71,653      $ 119,856      $ 119,856   

Cost of revenue:

            

Products and services (1)

     30,171        30,031        41,855        41,371        72,026        71,402   

Amortization of existing technologies (2)

     1,360        —          1,360        —          2,720        —     
                                                

Total cost of revenue

     31,531        30,031        43,215        41,371        74,746        71,402   
                                                

Gross profit

     16,672        18,172        28,438        30,282        45,110        48,454   

Gross margin %

     34.6     37.7     39.7     42.3     37.6     40.4

Research and development (3)

     11,847        11,277        13,086        11,400        24,933        22,677   

Sales and marketing (4)

     8,422        7,988        10,184        8,937        18,606        16,925   

General and Administrative (5)

     4,748        3,085        7,423        3,659        12,171        6,744   

Amortization of intangible assets (6)

     185        —          185        —          370        —     
                                                

Total operating expenses

     25,202        22,350        30,878        23,996        56,080        46,346   
                                                

Net operating income (loss)

     (8,530     (4,178     (2,440     6,286        (10,970     2,108   

Interest income

     74        74        103        103        177        177   

Interest expense

     (473     (473     (620     (620     (1,093     (1,093

Change in fair value of preferred stock warrants (7)

     (173     —          —          —          (173     —     

Other income / (expense)

     11        11        (2     (2     9        9   
                                                

Total other income / (expense)

     (561     (388     (519     (519     (1,080     (907

Provision for income taxes

     171        171        243        243        414        414   
                                                

Net income / (loss)

     (9,262     (4,737     (3,202     5,524        (12,464     787   
                                                

Preferred stock dividends (8)

     (900     —          —          —          (900     —     
                                                

Net income / (loss) attributable to common stockholders

   $ (10,162   $ (4,737   $ (3,202   $ 5,524      $ (13,364   $ 787   
                                                

Non-GAAP bridge to GAAP

            

(1) Cost of Sales (stock-based compensation)

       140          484          624   

(2) Cost of Sales (amortization of existing technologies)

       1,360          1,360          2,720   

(3) Research and development (stock-based compensation)

       570          1,686          2,256   

(4) Sales and marketing (stock-based compensation)

       434          1,247          1,681   

(5) General and administration (stock-based compensaton)

       1,663          3,764          5,427   

(6) Operating expense (amortization of intangible assets)

       185          185          370   

(7) Change in fair value of preferred stock warrants

       173          —            173   

(8) Preferred stock dividends

       900          —            900   
                              

Total Non-Cash Expenses

       5,425          8,726          14,151   
                              

GAAP net income / (loss) attributable to common stockholders

     $ (10,162     $ (3,202     $ (13,364
                              

Calix’s non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. In addition, the above non-GAAP Consolidated Statements of Operations are not based on a comprehensive set of accounting rules or principles.


Press Release    Page 4

 

Calix, Inc.

      

Historical Financials

      

Condensed Statements of Cash Flows 2010

      

($ in thousands)

 

      
     Qtr Ending
3/27/2010
    Qtr Ending
6/26/2010
    Ytd Ending
6/26/2010
 

Operating activities

      

Net cash used in operating activities

   $ 5,058      $ (5,258   $ (200
                        

Investing activities

      

Acquisition of property and equipment

     (1,481     (1,425     (2,906

Purchase of marketable securities

     (7,434     (49,133     (56,567

Sale of marketable securities

     6,708        8,500        15,208   
                        

Net cash provided by (used in) investing activities

     (2,207     (42,058     (44,265
                        

Financing activities

      

Proceeds from bank borrowings

     —          —          —     

Principal payments on bank borrowings

     —          (20,000     (20,000

Proceeds from exercise of stock options and warrants

     62        10        72   

Repurchase of common and preferred stock

     —          —          —     

Proceeds from initial public offering of common stock

     46,229        11,064        57,293   
                        

Net cash provided by (used in) financing activities

     46,291        (8,926     37,365   
                        

Net increase (decrease) in cash and cash equivalents

     49,142        (56,242     (7,100

Cash and cash equivalents at beginning of period

     31,821        80,963        31,821   
                        

Cash and cash equivalents at end of period

   $ 80,963      $ 24,721      $ 24,721   
                        


Press Release    Page 5

 

Calix, Inc.

                   

Historical Financials

                   

Non-GAAP Income Statements 2009

                   

($ in thousands)

                   
     GAAP     Non-GAAP     GAAP     Non-GAAP     GAAP     Non-GAAP     GAAP     Non-GAAP     GAAP     Non-GAAP  
    Qtr Ending
3/28/2009
    Qtr Ending
3/28/2009
    Qtr Ending
6/27/2009
    Qtr Ending
6/27/2009
    Qtr Ending
9/26/2009
    Qtr Ending
9/26/2009
    Qtr Ending
12/31/2009
    Qtr Ending
12/31/2009
    Ytd Ending
12/31/2009
    Ytd Ending
12/31/2009
 

Revenue

  $ 37,146      $ 37,146      $ 47,842      $ 47,842      $ 59,600      $ 59,600      $ 88,359      $ 88,359      $ 232,947      $ 232,947   

Cost of revenue:

                   

Products and services (1)

    25,391        25,212        31,076        30,908        37,117        36,948        57,279        57,113        150,863        150,181   

Amortization of existing technologies (2)

    1,360        —          1,360        —          1,360        —          1,360        —          5,440        —     
                                                                               

Total cost of revenue

    26,751        25,212        32,436        30,908        38,477        36,948        58,639        57,113        156,303        150,181   
                                                                               

Gross profit

    10,395        11,934        15,406        16,934        21,123        22,652        29,720        31,246        76,644        82,766   

Gross margin %

    28.0     32.1     32.2     35.4     35.4     38.0     33.6     35.4     32.9     35.5

Research and development (3)

    10,468        9,739        10,742        10,123        11,977        11,356        12,945        12,257        46,132        43,475   

Sales and marketing (4)

    7,209        6,754        7,988        7,566        8,494        8,084        9,795        9,343        33,486        31,747   

General and Administrative (5)

    3,663        2,753        4,238        3,270        3,728        2,688        3,984        2,784        15,613        11,495   

Amortization of intangible assets (6)

    185        —          185        —          185        —          185        —          740        —     
                                                                               

Total operating expenses

    21,525        19,246        23,153        20,959        24,384        22,128        26,909        24,384        95,971        86,717   
                                                                               

Net operating income (loss)

    (11,130     (7,312     (7,747     (4,025     (3,261     524        2,811        6,862        (19,327     (3,951

Interest income

    79        79        27        27        38        38        101        101        245        245   

Interest expense

    (943     (943     (1,079     (1,079     (1,404     (1,404     (441     (441     (3,867     (3,867

Change in fair value of preferred stock warrants (7)

    —          —          95        —          (23     —          (35     —          37        —     

Other income / (expense)

    64        64        40        40        9        9        6        6        119        119   
                                                                               

Total other income / (expense)

    (800     (800     (917     (1,012     (1,380     (1,357     (369     (334     (3,466     (3,503
                                                                               

Provision for income taxes

    130        130        138        138        (217     (217     (403     (403     (352     (352
                                                                               

Net income / (loss)

    (12,060     (8,242     (8,802     (5,175     (4,424     (616     2,845        6,931        (22,441     (7,102
                                                                               

Preferred stock dividends (8)

    (652     —          —          —          (2,389     —          (706     —          (3,747     —     
                                                                               

Net income / (loss) attributable to common stockholders

  $ (12,712   $ (8,242   $ (8,802   $ (5,175   $ (6,813   $ (616   $ 2,139      $ 6,931      $ (26,188   $ (7,102
                                                                               

Non-GAAP bridge to GAAP

                   

(1) Cost of Sales (stock-based compensation)

      179          168          169          166          682   

(2) Cost of Sales (amortization of existing technologies)

      1,360          1,360          1,360          1,360          5,440   

(3) Research and development (stock-based compensation)

      729          619          621          688          2,657   

(4) Sales and marketing (stock-based compensation)

      455          422          410          452          1,739   

(5) General and administration (stock-based compensaton)

      910          968          1,040          1,200          4,118   

(6) Operating expense (amortization of intangible assets)

      185          185          185          185          740   

(7) Change in fair value of preferred stock warrants

      —            (95       23          35          (37

(8) Preferred stock dividends

      652          —            2,389          706          3,747   
                                                 

Total Non-Cash Expenses

      4,470          3,627          6,197          4,792          19,086   
                                                 

GAAP net income / (loss) attributable to common stockholders

    $ (12,712     $ (8,802     $ (6,813     $ 2,139        $ (26,188
                                                 

Calix’s non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. In addition, the above non-GAAP Consolidated Statements of Operations are not based on a comprehensive set of accounting rules or principles.


Press Release    Page 6

 

Calix, Inc.

Historical Financials

Condensed Balance Sheets 2009

($ in thousands)

 

     3/28/2009     6/27/2009     9/26/2009     12/31/2009  

Assets

        

Current assets:

        

Cash and cash equivalents

   $ 18,980      $ 47,884      $ 55,622      $ 31,821   

Marketable securities

     —          —          6,272        36,228   

Restricted cash

     2,815        628        628        629   

Accounts receivable, net

     24,665        34,830        42,515        46,992   

Inventory

     19,744        17,508        13,917        18,556   

Deferred cost of goods sold

     14,510        18,073        19,370        16,468   

Prepaids and other current assets

     2,022        1,616        1,712        4,018   
                                

Total current assets

     82,736        120,539        140,036        154,712   

Property and equipment, net

     9,383        8,890        10,900        11,293   

Goodwill

     65,576        65,576        65,576        65,576   

Intangible assets, net

     11,330        9,785        8,240        6,695   

Other assets

     360        309        681        2,840   
                                

Total assets

   $ 169,385      $ 205,099      $ 225,433      $ 241,116   
                                

Liabilities, convertible preferred stock and stockholder’s deficit

        

Current liabilities:

        

Accounts payable

   $ 6,187      $ 8,266      $ 10,669      $ 14,635   

Accrued liabilities

     15,896        14,640        19,221        28,629   

Preferred stock warrant liabilities

     232        137        160        195   

Loans payable

     —          —          1,111        3,333   

Current portion of deferred revenue

     26,144        33,044        34,242        29,921   
                                

Total current liabilities

     48,459        56,087        65,403        76,713   

Loan payable

     21,000        21,000        18,889        16,667   

Long-term portion of deferred revenue

     4,758        4,738        5,260        6,556   

Other long-term liabilities

     963        1,424        959        910   

Convertible preferred stock

     427,055        461,313        478,981        479,628   
       —         

Stockholders’ deficit:

       —          —       

Common stock

     100        100        100        102   

Additional paid-in capital

     45,758        47,945        50,185        52,739   

Other comprehensive income

     —          —          (23     (17

Accumulated deficit

     (378,708     (387,508     (394,321     (392,182
                                

Total stockholders’ deficit

     (332,850     (339,463     (344,059     (339,358

Total liabilities, convertible preferred stock and

        
                                

Stockholders’ deficit

   $ 169,385      $ 205,099      $ 225,433      $ 241,116   
                                


Press Release    Page 7

 

Calix, Inc.

Historical Financials

Condensed Statements of Cash Flows 2009

($ in thousands)

  

  

  

  

     Qtr Ending
3/28/2009
    Qtr Ending
6/27/2009
    Qtr Ending
9/26/2009
    Qtr Ending
12/31/2009
    Ytd Ending
12/31/2009
 

Operating activities

          

Net cash used in operating activities

   $ (3,432   $ (4,595   $ 1,681      $ 7,736      $ 1,390   
                                        

Investing activities

          

Acquisition of property and equipment

     (790     (769     (1,927     (1,578     (5,064

Purchase of marketable securities

     —          —          (6,295     (29,950     (36,245

Sale of marketable securities

     —          —          —          —          —     
                                        

Net cash provided by (used in) investing activities

     (790     (769     (8,222     (31,528     (41,309
                                        

Financing activities

          

Proceeds from bank borrowings

     —          —          20,000        —          20,000   

Principal payments on bank borrowings

     —          —          (21,000     —          (21,000

Proceeds from Series J investors, net of issuance costs

     —          34,258        15,279        (59     49,478   

Proceeds from exercise of stock options and warrants

     —          10        —          50        60   

Repurchase of common and preferred stock

     (12     —          —          —          (12

Proceeds from initial public offering of common stock

     —          —          —          —          —     
                                        

Net cash provided by (used in) financing activities

     (12     34,268        14,279        (9     48,526   
                                        

Net increase (decrease) in cash and cash equivalents

     (4,234     28,904        7,738        (23,801     8,607   

Cash and cash equivalents at beginning of period

     23,214        18,980        47,884        55,622        23,214   
                                        

Cash and cash equivalents at end of period

   $ 18,980      $ 47,884      $ 55,622      $ 31,821      $ 31,821   
                                        


Press Release    Page 8

 

Calix, Inc.

Historical Financials

Non-GAAP Income Statements 2008

($ in thousands)

    GAAP     Non-GAAP     GAAP     Non-GAAP     GAAP     Non-GAAP     GAAP     Non-GAAP     GAAP     Non-GAAP  
    Qtr
Ending
3/31/2008
    Qtr
Ending
3/31/2008
    Qtr
Ending
6/30/2008
    Qtr
Ending
6/30/2008
    Qtr
Ending
9/29/2008
    Qtr
Ending
9/29/2008
    Qtr
Ending
12/31/2008
    Qtr
Ending
12/31/2008
    Ytd
Ending
12/31/2008
    Ytd
Ending
12/31/2008
 

Revenue

  $ 59,661      $ 59,661      $ 60,820      $ 60,820      $ 59,317      $ 59,317      $ 70,665      $ 70,665      $ 250,463      $ 250,463   

Cost of revenue:

                   

Products and services (1)

    41,358        41,227        39,331        39,121        39,158        38,967        46,078        45,881        165,925        165,196   

Amortization of existing technologies (2)

    1,360        —          1,360        —          1,360        —          1,360        —          5,440        —     
                                                                               

Total cost of revenue

    42,718        41,227        40,691        39,121        40,518        38,967        47,438        45,881        171,365        165,196   
                                                                               

Gross profit

    16,943        18,434        20,129        21,699        18,799        20,350        23,227        24,784        79,098        85,267   

Gross margin %

    28.4     30.9     33.1     35.7     31.7     34.3     32.9     35.1     31.6     34.0

Research and development (3)

    10,850        10,291        11,900        10,810        11,055        10,288        10,543        9,770        44,348        41,159   

Sales and marketing (4)

    7,303        6,956        8,396        7,811        7,814        7,354        8,114        7,618        31,627        29,739   

General and Administrative (5)

    3,392        2,525        4,066        2,741        3,948        3,040        3,847        2,813        15,253        11,119   

Amortization of intangible assets (6)

    185        —          185        —          185        —          185        —          740        —     
                                                                               

Total operating expenses

    21,730        19,772        24,547        21,362        23,002        20,682        22,689        20,201        91,968        82,017   
                                                                               

Net operating income (loss)

    (4,787     (1,338     (4,418     337        (4,203     (332     538        4,583        (12,870     3,250   

Interest income

    221        221        101        101        153        153        145        145        620        620   

Interest expense

    (215     (215     (164     (164     (809     (809     (901     (901     (2,089     (2,089

Change in fair value of preferred stock warrants (7)

    546        —          —          —          557        —          226        —          1,329        —     

Other income / (expense)

    10        10        (23     (23     14        14        9        9        10        10   
                                                                               

Total other income / (expense)

    562        16        (86     (86     (85     (642     (521     (747     (130     (1,459
                                                                               

Provision for income taxes

    45        45        101        101        73        73        (300     (300     (81     (81
                                                                               

Net income / (loss)

    (4,270     (1,367     (4,605     150        (4,361     (1,047     317        4,136        (12,919     1,872   
                                                                               

Preferred stock dividends (8)

    (479     —          (540     —          (2,441     —          (605     —          (4,065     —     
                                                                               

Net income / (loss) attributable to common stockholders

  $ (4,749   $ (1,367   $ (5,145   $ 150      $ (6,802   $ (1,047   $ (288   $ 4,136      $ (16,984   $ 1,872   
                                                                               

Non-GAAP bridge to GAAP

                   

(1) Cost of Sales (stock-based compensation)

      131          210          191          197          729   

(2) Cost of Sales (amortization of existing technologies)

      1,360          1,360          1,360          1,360          5,440   

(3) Research and development (stock-based compensation)

      559          1,090          767          773          3,189   

(4) Sales and marketing (stock-based compensation)

      347          585          460          496          1,888   

(5) General and administration (stock-based compensation)

      867          1,325          908          1,034          4,134   

(6) Operating expense (amortization of intangible assets)

      185          185          185          185          740   

(7) Change in fair value of preferred stock warrants

      (546       —            (557       (226       (1,329
(8) Preferred stock dividends       479          540          2,441          605          4,065   
                                                 

Total Non-Cash Expenses

      3,382          5,295          5,755          4,424          18,856   
                                                 

GAAP net income / (loss) attributable to common stockholders

    $ (4,749     $ (5,145     $ (6,802     $ (288     $ (16,984
                                                 

Calix’s non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. In addition, the above non-GAAP Consolidated Statements of Operations are not based on a comprehensive set of accounting rules or principles.


Press Release    Page 9

 

Calix, Inc.         
Historical Financials         
Condensed Balance Sheets 2008         
($ in thousands)         
     3/31/2008     6/30/2008     9/29/2008     12/31/2008  

Assets

        

Current assets:

        

Cash and cash equivalents

   $ 8,564      $ 22,354      $ 27,735      $ 23,214   

Marketable securities

     5,029        3,011        —          —     

Restricted cash

     4,625        —          4,840        4,856   

Accounts receivable, net

     33,040        38,905        36,265        32,783   

Inventory

     14,323        13,798        17,392        23,397   

Deferred cost of goods sold

     17,922        18,596        20,719        14,208   

Prepaids and other current assets

     1,321        1,932        1,608        2,247   
                                

Total current assets

     84,825        98,596        108,559        100,705   

Property and equipment, net

     9,613        9,403        9,495        9,940   

Goodwill

     65,576        65,576        65,576        65,576   

Intangible assets, net

     17,510        15,965        14,420        12,875   

Other assets

     386        391        395        359   
                                

Total assets

   $ 177,910      $ 189,931      $ 198,445      $ 189,455   
                                

Liabilities, convertible preferred stock and stockholder’s deficit

        

Current liabilities:

        

Accounts payable

   $ 11,864      $ 24,188      $ 18,930      $ 18,490   

Accrued liabilities

     15,230        17,073        18,608        16,347   

Preferred stock warrant liabilities

     1,015        1,015        457        232   

Loans payable

     11,000        9,750        —          —     

Current portion of deferred revenue

     30,434        30,875        34,095        24,233   
                                

Total current liabilities

     69,543        82,901        72,090        59,302   

Related party loan payable

     —          —          21,000        21,000   

Long-term portion of deferred revenue

     3,833        3,874        4,200        4,580   

Other long-term liabilities

     —          —            567   

Convertible preferred stock

     422,817        423,357        425,797        426,403   
       —         

Stockholders’ deficit:

       —          —       

Common stock

     100        100        100        100   

Additional paid-in capital

     35,337        38,590        40,964        43,497   

Other comprehensive income

     39        13        —          —     

Accumulated deficit

     (353,759     (358,904     (365,706     (365,994
                                

Total stockholders’ deficit

     (318,283     (320,201     (324,642     (322,397
                                

Total liabilities, convertible preferred stock and Stockholders’ deficit

   $ 177,910      $ 189,931      $ 198,445      $ 189,455   
                                


Press Release    Page 10

 

Calix, Inc.

          

Historical Financials

          

Condensed Statements of Cash Flows 2008

          

($ in thousands)

          
     Qtr Ending
3/31/2008
    Qtr Ending
6/30/2008
    Qtr Ending
9/29/2008
    Qtr Ending
12/31/2008
    Ytd Ending
12/31/2008
 

Operating activities

          

Net cash used in operating activities

   $ (9,534   $ 14,212      $ (7,478   $ (2,751   $ (5,551
                                        

Investing activities

          

Acquisition of property and equipment

     (1,036     (1,151     (1,436     (1,804     (5,427

Purchase of marketable securities

     —          —          —          —          —     

Sale of marketable securities

     3,286        1,991        2,999        —          8,276   
                                        

Net cash provided by (used in) investing activities

     2,251        840        1,563        (1,805     2,849   
                                        

Financing activities

          

Proceeds from bank borrowings

     —          —          21,000        —          21,000   

Principal payments on bank borrowings

     (5,512     (1,250     (9,750     —          (16,512

Proceeds from Series J investors, net of issuance costs

     —          —          —          —          —     

Proceeds from exercise of stock options and warrants

     17        7        46        35        105   

Repurchase of common and preferred stock

     —          (19     —          —          (19

Proceeds from initial public offering of common stock

     —          —          —          —          —     
                                        

Net cash provided by (used in) financing activities

     (5,495     (1,262     11,296        35        4,574   
                                        

Net increase (decrease) in cash and cash equivalents

     (12,778     13,790        5,381        (4,521     1,872   

Cash and cash equivalents at beginning of period

     21,342        8,564        22,354        27,735        21,342   
                                        

Cash and cash equivalents at end of period

   $ 8,564      $ 22,354      $ 27,735      $ 23,214      $ 23,214   
                                        

# # #